Home News Terrifying! ‘Immune Escape’ May be Happening

Terrifying! ‘Immune Escape’ May be Happening

21
0
terrifying!-‘immune-escape’-may-be-happening

Trial Site News:

University of Chile Scientists’ Study Indicates Sinovac’s Vaccine Elicits More Transmissible & Potent Variant called Lambda

The COVID-19 variant of concern (VoC) called C.37 or the “Lambda variant,” was probably first identified in Peru about one year ago, which fuels growing concern that mutations could overpower existing COVID-19 vaccines.

The World Health Organization (WHO) reports that this mutant variant could not only boost transmissibility but also strengthen the pathogen’s resistance to vaccine-elicited neutralizing antibodies. It is not known yet what the impact of this variant will be, reports a new study, but the investigators do speculate that there could be a result of this viral adaptation to the CoronaVac vaccine, produced by the Chinese corporation Sinovac. 

That’s right: if this study is correct, the CoronaVac vaccine could be correlated to a mutation, one that’s led to a more transmissible and potent mutant. The authors suggest mass vaccination programs conducted directly in SARS-CoV-2 hotspots should be coupled with “strict genomic surveillance.”

Here’s a background on ‘Immune Escape’ – Structural Details of How SARS-CoV-2 Variants Escape Immune Response Detailed in New Study

Led by corresponding authors Ricardo Soto-Rifo and Fernando Valiente-Echeverría Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile, the yet to be published study titled “Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda” is available on the preprint server medRxiv

It’s a short and readable article, but here is the terrifying bottom line:

Conclusions: Our results indicate that mutations present in the spike protein of the Lambda

variant of interest confer increased infectivity and immune escape from neutralizing antibodies

elicited by CoronaVac. These data reinforce the idea that massive vaccination campaigns in

countries with high SARS-CoV-2 circulation must be accompanied by strict genomic

surveillance allowing the identification of new isolates carrying spike mutations and

immunology studies aimed to determine the impact of these mutations in immune escape and

vaccines breakthrough

THE STUDY: Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda

More at Trial Site News

Buy on Amazon!


Web Hosting